SCHEMBL8807299

SCHEMBL8807299

COC(=O)CCn1ccc(-c2c(-c3ccccc3)nn3ccccc23)cc1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.49
IGF1R P08069 1/20 0.42
MAPK1 P28482 3/20 0.42
EGFR P00533 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
TP53 P04637 1/20 0.39
AKT1 P31749 1/20 0.39
TSHR P16473 1/20 0.38
RAF1 P04049 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808264 0.89 ADORA1 (0.59) ADORA1IGF1RMAPK1EGFRKDM4E
SCHEMBL9773260 0.84 ADORA1 (0.52) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8810075 0.83 ADORA1 (0.44) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8808815 0.82 ADORA1 (0.46) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8808388 0.81 ADORA1 (0.42) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8808083 0.80 ADORA1 (0.73) ADORA1IGF1RMAPK1KMT2ALMNA
SCHEMBL8808962 0.78 ADORA1 (0.54) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8812594 0.77 ADORA1 (0.48) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8808435 0.76 PDE4B (0.49) ADORA1IGF1RMAPK1EGFRKMT2A
SCHEMBL8810287 0.75 ADORA1 (0.44) ADORA1IGF1RMAPK1EGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0379979-B1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-19 EP disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed